Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NINLARO All-Case Surveillance in Relapsed/Refractory Multiple Myeloma
jRCT1080223537Completed
- Sponsor
- Takeda
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ixazomib in multiple myeloma (MM), sponsored by Takeda. Started May 2017; status: completed.
02
Drugs
ixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on jRCT1080223537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223537.